View ValuationUV Germi 将来の成長Future 基準チェック /06現在、 UV Germiの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Machinery 収益成長22.1%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBoard Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Julien Pourquery was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • Jan 07UV Germi SA (ENXTPA:ALUVI) announces an Equity Buyback.UV Germi SA (ENXTPA:ALUVI) announces a share repurchase program. Under the program, the company will repurchase nominal amount of €0.12 million worth of shares. The purpose of program is to reduce capital of the company. The purchased shares will be cancelled.お知らせ • Jul 16Willy Fortunato acquired 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas for €1.95 million.Willy Fortunato acquired 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas for €1.95 million on July 15, 2025. Willy Fortunato acquired 24.38% of the capital, represented by 786,608 shares for Unit Price: €2.48 per share. Willy Fortunato now holds 26.64% of the capital and voting rights of UV Germi. André Bordas and Bernadette Bordas announced their intention to resign from their positions as Chairman of the Board and Director, respectively. André Bordas was appointed as honorary president. The Board of Directors has decided to modify the conditions of exercise of the general management by grouping the functions of Chairman and Chief Executive Officer, which are assumed by Willy Fortunato. Sandrine Bordas will continue to serve as Deputy Managing Director and Director until the end of her term. Willy Fortunato completed the acquisition of 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas on July 15, 2025.お知らせ • May 24UV Germi SA, Annual General Meeting, Jun 27, 2025UV Germi SA, Annual General Meeting, Jun 27, 2025. Location: zac de la nau, saint viance FranceReported Earnings • Oct 18First half 2024 earnings releasedFirst half 2024 results: Revenue: €4.75m (up 5.1% from 1H 2023). Net income: €480.0k (down 16% from 1H 2023). Profit margin: 10% (down from 13% in 1H 2023).New Risk • Sep 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.90m (US$9.86m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€8.90m market cap, or US$9.86m). Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Aug 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €3.07, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 15x in the Machinery industry in Germany. Total loss to shareholders of 48% over the past year.Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.27, the stock trades at a trailing P/E ratio of 38x. Average trailing P/E is 15x in the Machinery industry in Germany. Total loss to shareholders of 36% over the past year.Valuation Update With 7 Day Price Move • Jun 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €2.63, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 16x in the Machinery industry in Germany. Total loss to shareholders of 40% over the past year.お知らせ • May 26UV Germi SA, Annual General Meeting, Jun 28, 2024UV Germi SA, Annual General Meeting, Jun 28, 2024. Location: zac de la nau, saint viance FranceReported Earnings • Apr 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €8.48m (up 16% from FY 2022). Net income: €290.1k (up 340% from FY 2022). Profit margin: 3.4% (up from 0.9% in FY 2022). The increase in margin was driven by higher revenue.Board Change • Apr 25No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €3.83, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 4.3% over the past year.Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.97, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 8.5% over the past year.New Risk • Nov 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.92m (US$9.78m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (€8.92m market cap, or US$9.78m). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (2.5% increase in shares outstanding).Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €2.95, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 20% over the past year.New Risk • Jul 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Market cap is less than US$100m (€18.8m market cap, or US$20.6m).New Risk • Jul 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€18.6m market cap, or US$20.5m).Reported Earnings • May 03Full year 2022 earnings releasedFull year 2022 results: Revenue: €7.63m (up 17% from FY 2021). Net income: €70.0k (up €939.5k from FY 2021). Profit margin: 0.9% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Machinery industry in Germany.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Oct 22First half 2022 earnings releasedFirst half 2022 results: Revenue: €4.33m (up 25% from 1H 2021). Net income: €310.0k (up €387.7k from 1H 2021). Profit margin: 7.2% (up from net loss in 1H 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Machinery industry in Germany.Reported Earnings • Apr 28Full year 2021 earnings releasedFull year 2021 results: Revenue: €7.14m (up 4.1% from FY 2020). Net loss: €870.0k (down 312% from profit in FY 2020). Over the next year, revenue is forecast to grow 15%, compared to a 9.9% growth forecast for the industry in Germany.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 24% share price gain to €4.31, the stock trades at a forward P/E ratio of 66x. Average forward P/E is 13x in the Machinery industry in Germany.Valuation Update With 7 Day Price Move • Feb 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.36, the stock trades at a forward P/E ratio of 67x. Average forward P/E is 13x in the Machinery industry in Germany.Board Change • Dec 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、UV Germi は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:1NY - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202570N/AN/AN/A12/31/202491N/AN/AN/A9/30/202490N/AN/AN/A6/30/202490N/AN/AN/A3/31/202480N/AN/AN/A12/31/202380N/AN/AN/A9/30/202380N/AN/AN/A6/30/202380N/AN/AN/A3/31/202380N/AN/AN/A12/31/202270N/AN/AN/A9/30/202270N/AN/AN/A6/30/202270N/AN/AN/A3/31/20227-1N/AN/AN/A12/31/20217-1N/AN/AN/A9/30/202170N/AN/AN/A6/30/202170N/AN/AN/A3/31/202170N/AN/AN/A12/31/202070N/AN/AN/A9/30/202070N/AN/AN/A6/30/202060N/AN/AN/A3/31/202060N/AN/AN/A12/31/201960N/AN/AN/A9/30/201960N/AN/AN/A6/30/201960N/AN/AN/A3/31/201960N/AN/AN/A12/31/201850N/AN/AN/A9/30/201850N/AN/AN/A6/30/201850N/AN/AN/A3/31/201850N/AN/AN/A12/31/201750N/AN/AN/A12/31/201650N/A0N/A12/31/201540N/A0N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 1NYの予測収益成長が 貯蓄率 ( 2.1% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 1NYの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 1NYの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 1NYの収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 1NYの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 1NYの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCapital-goods 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/10 14:35終値2026/08/07 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋UV Germi SA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。3 アナリスト機関Charles-Louis PlanadeTPICAP MidcapValerie Ducreux DieppeTPICAP MidcapChristel ClemeTPICAP Midcap
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Julien Pourquery was the last director to join the board, commencing their role in 2023. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • Jan 07UV Germi SA (ENXTPA:ALUVI) announces an Equity Buyback.UV Germi SA (ENXTPA:ALUVI) announces a share repurchase program. Under the program, the company will repurchase nominal amount of €0.12 million worth of shares. The purpose of program is to reduce capital of the company. The purchased shares will be cancelled.
お知らせ • Jul 16Willy Fortunato acquired 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas for €1.95 million.Willy Fortunato acquired 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas for €1.95 million on July 15, 2025. Willy Fortunato acquired 24.38% of the capital, represented by 786,608 shares for Unit Price: €2.48 per share. Willy Fortunato now holds 26.64% of the capital and voting rights of UV Germi. André Bordas and Bernadette Bordas announced their intention to resign from their positions as Chairman of the Board and Director, respectively. André Bordas was appointed as honorary president. The Board of Directors has decided to modify the conditions of exercise of the general management by grouping the functions of Chairman and Chief Executive Officer, which are assumed by Willy Fortunato. Sandrine Bordas will continue to serve as Deputy Managing Director and Director until the end of her term. Willy Fortunato completed the acquisition of 24.38% stake in UV Germi SA (ENXTPA:ALUVI) from André Bordas, Bernadette Bordas, Sandrine Bordas on July 15, 2025.
お知らせ • May 24UV Germi SA, Annual General Meeting, Jun 27, 2025UV Germi SA, Annual General Meeting, Jun 27, 2025. Location: zac de la nau, saint viance France
Reported Earnings • Oct 18First half 2024 earnings releasedFirst half 2024 results: Revenue: €4.75m (up 5.1% from 1H 2023). Net income: €480.0k (down 16% from 1H 2023). Profit margin: 10% (down from 13% in 1H 2023).
New Risk • Sep 14New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.90m (US$9.86m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (€8.90m market cap, or US$9.86m). Minor Risks Share price has been volatile over the past 3 months (9.0% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Aug 27Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €3.07, the stock trades at a trailing P/E ratio of 34.6x. Average trailing P/E is 15x in the Machinery industry in Germany. Total loss to shareholders of 48% over the past year.
Valuation Update With 7 Day Price Move • Aug 15Investor sentiment improves as stock rises 17%After last week's 17% share price gain to €3.27, the stock trades at a trailing P/E ratio of 38x. Average trailing P/E is 15x in the Machinery industry in Germany. Total loss to shareholders of 36% over the past year.
Valuation Update With 7 Day Price Move • Jun 19Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to €2.63, the stock trades at a trailing P/E ratio of 30.1x. Average trailing P/E is 16x in the Machinery industry in Germany. Total loss to shareholders of 40% over the past year.
お知らせ • May 26UV Germi SA, Annual General Meeting, Jun 28, 2024UV Germi SA, Annual General Meeting, Jun 28, 2024. Location: zac de la nau, saint viance France
Reported Earnings • Apr 28Full year 2023 earnings releasedFull year 2023 results: Revenue: €8.48m (up 16% from FY 2022). Net income: €290.1k (up 340% from FY 2022). Profit margin: 3.4% (up from 0.9% in FY 2022). The increase in margin was driven by higher revenue.
Board Change • Apr 25No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 05Investor sentiment improves as stock rises 15%After last week's 15% share price gain to €3.83, the stock trades at a trailing P/E ratio of 33.8x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 4.3% over the past year.
Valuation Update With 7 Day Price Move • Dec 09Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.97, the stock trades at a trailing P/E ratio of 30.3x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 8.5% over the past year.
New Risk • Nov 28New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: €8.92m (US$9.78m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (11% average weekly change). Market cap is less than US$10m (€8.92m market cap, or US$9.78m). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (2.5% increase in shares outstanding).
Valuation Update With 7 Day Price Move • Nov 24Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to €2.95, the stock trades at a trailing P/E ratio of 29.8x. Average trailing P/E is 13x in the Machinery industry in Germany. Total loss to shareholders of 20% over the past year.
New Risk • Jul 27New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 3.4% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (3.4% increase in shares outstanding). Market cap is less than US$100m (€18.8m market cap, or US$20.6m).
New Risk • Jul 11New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 10% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (10% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (€18.6m market cap, or US$20.5m).
Reported Earnings • May 03Full year 2022 earnings releasedFull year 2022 results: Revenue: €7.63m (up 17% from FY 2021). Net income: €70.0k (up €939.5k from FY 2021). Profit margin: 0.9% (up from net loss in FY 2021). The move to profitability was driven by higher revenue. Revenue is forecast to grow 25% p.a. on average during the next 2 years, compared to a 4.5% growth forecast for the Machinery industry in Germany.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 22First half 2022 earnings releasedFirst half 2022 results: Revenue: €4.33m (up 25% from 1H 2021). Net income: €310.0k (up €387.7k from 1H 2021). Profit margin: 7.2% (up from net loss in 1H 2021). Revenue is forecast to grow 23% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Machinery industry in Germany.
Reported Earnings • Apr 28Full year 2021 earnings releasedFull year 2021 results: Revenue: €7.14m (up 4.1% from FY 2020). Net loss: €870.0k (down 312% from profit in FY 2020). Over the next year, revenue is forecast to grow 15%, compared to a 9.9% growth forecast for the industry in Germany.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Valuation Update With 7 Day Price Move • Mar 16Investor sentiment improved over the past weekAfter last week's 24% share price gain to €4.31, the stock trades at a forward P/E ratio of 66x. Average forward P/E is 13x in the Machinery industry in Germany.
Valuation Update With 7 Day Price Move • Feb 26Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.36, the stock trades at a forward P/E ratio of 67x. Average forward P/E is 13x in the Machinery industry in Germany.
Board Change • Dec 22No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). Deputy CEO & Director Sandrine Bordas was the last director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.